[HTML][HTML] A global, propensity-score matched analysis of patients receiving artificial urinary sphincters and the risk of complications, infections, and re-interventions

ZJ Prebay, D Ebbott, H Foss, M Li… - … Andrology and Urology, 2023 - ncbi.nlm.nih.gov
ZJ Prebay, D Ebbott, H Foss, M Li, PH Chung
Translational Andrology and Urology, 2023ncbi.nlm.nih.gov
Background Artificial urinary sphincters (AUS) are the gold standard treatment for patients
with stress urinary incontinence. However, risk factors for implant infection, complication, or
re-intervention (removal, repair, replacement) are incompletely understood. We sought to
understand the impact of various patient factors on the risk of device failure by leveraging a
large, multi-national research database. Methods We queried the TriNetX database for all
adult patients undergoing AUS. We evaluated the impact of age, body mass index, race …
Abstract
Background
Artificial urinary sphincters (AUS) are the gold standard treatment for patients with stress urinary incontinence. However, risk factors for implant infection, complication, or re-intervention (removal, repair, replacement) are incompletely understood. We sought to understand the impact of various patient factors on the risk of device failure by leveraging a large, multi-national research database.
Methods
We queried the TriNetX database for all adult patients undergoing AUS. We evaluated the impact of age, body mass index, race, ethnicity, diabetes (DM), smoking history, history of radiation therapy (RT), history of radical prostatectomy (RP) and history of urethroplasty on select clinical outcomes. Our primary outcome was the need for re-intervention defined by current procedural terminology (CPT) codes. Secondary outcomes included overall device complication rate and infection rate defined by international classification of diseases (ICD) codes. Analytics were performed on TriNetX which calculated risk ratios (RR) and Kaplan-Meier (KM) survival. We evaluated our outcomes first on the entire population and then repeated analyses for each individual comparison cohort using the remaining demographic variables to perform propensity score matching (PSM).
Results
The overall rates of AUS re-intervention, complication and infection were 23.4%, 24.1% and 6.4%, respectively. KM analysis showed median AUS survival (no need for re-intervention) at 10.6 years and projected 20-year survival probability at 31.3%. Patients with a history of smoking or urethroplasty were at higher risk of AUS complication and re-intervention. Patients with DM or a history of RT were at higher risk of AUS infection. Patients with a history of RT were at higher risk of AUS complication. All risk factors besides race showed a difference in device removal itself.
Conclusions
To our knowledge, this represents the largest series to follow patients with an AUS. About one-quarter of AUS patients needed re-intervention. Multiple demographics place patients at increased risk of re-intervention, infection, or complication. These results can help guide patient selection and counseling with the goal of reducing complications.
ncbi.nlm.nih.gov
以上显示的是最相近的搜索结果。 查看全部搜索结果